Post-Menopausal Osteoporosis Clinical Trial
A study to asses the safety and efficacy of MK0429 in postmenopausal women with osteoporosis.
n/a
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double-Blind, Primary Purpose: Treatment
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT01224717 -
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Oral Doses of PTH134 in Post-menopausal Women
|
Phase 1 | |
| Completed |
NCT00551174 -
A Study of Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis Who Have Received Previous Bonviva Treatment
|
Phase 4 | |
| Completed |
NCT00984893 -
Intra-venous Zoledronic Acid Once Yearly
|
N/A | |
| Withdrawn |
NCT01826656 -
Bone Healing in Healthy and Post-menopausal Osteoporotic Women
|
N/A | |
| Completed |
NCT00718861 -
3 yr Efficacy & Safety Study of Zoledronic Acid in Post-menopausal Women With Osteoporosis Treated With Zol Acid for 6 Yrs
|
Phase 3 | |
| Completed |
NCT00081653 -
A Study of Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis Previously Treated With Bonviva
|
Phase 4 | |
| Completed |
NCT00503113 -
A Study of Bonviva (Ibandronate) and Alendronate on Renal Function in Postmenopausal Women With Osteoporosis at High Risk for Renal Disease.
|
Phase 4 | |
| Completed |
NCT00150969 -
Vitamin K Supplementation in Post-Menopausal Osteopenia
|
Phase 3 | |
| Completed |
NCT03432533 -
A Comparison of Subject-administered Romosozumab With Healthcare Provider-administered Romosozumab for Osteoporosis
|
Phase 3 | |
| Completed |
NCT00545779 -
BONCURE Study: A Study of Monthly Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis on Bisphosphonate Therapy.
|
Phase 4 | |
| Active, not recruiting |
NCT01232647 -
Vitamin K as Additive Treatment in Osteoporosis
|
Phase 2/Phase 3 | |
| Completed |
NCT00666627 -
Bisphosphonate Action on the Appendicular Skeleton: Evidence for Differential Effects
|
Phase 2 |